PHARMACOTHERAPEUTIC FOLLOW-UP DIRECTED TO DOMESTIC ANIMALS: WOULD IT BE FEASIBLE?

Abstract

The overall performance in the area of human health has directed its focus to patient care, taking the medicine as the background. In this sense, the human pharmacotherapeutic follow-up (which is part of the Pharmaceutical Care) has been a great tool to aid the detection of Drug Related Problems (DRP) so they can be avoided or identified in order to prevent / minimize the emergence of Drug Negative Outcomes (DNO). Considering the need of therapeutic success as a result to obtain in health care, a reflection on the possibility of a follow-up model (Dáder modified) to be adapted and applied to the pharmacotherapeutic monitoring animal area, particularly, in domestic animals with chronic use of medications is presented.